Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Lemaitre Vascular Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 297
- +20 vs. Q2 2025
- Shares held
- 21.0M
- −50.4K (−0.2%) vs. Q2 2025
- Total value
- $1.84B
- +$88.9M (+5.1%) vs. Q2 2025
- New holders
- 43
- 104 more added
- Sold out
- 23
- 106 more reduced
6 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LMAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 327 | $2.20B |
| Q1 2026 | 341 | $2.42B |
| Q4 2025 | 297 | $1.73B |
| Q3 2025 | 297 | $1.84B |
| Q2 2025 | 283 | $1.76B |
| Q1 2025 | 288 | $1.77B |
| Q4 2024 | 307 | $1.95B |
| Q3 2024 | 291 | $1.95B |
| Q2 2024 | 262 | $1.69B |
| Q1 2024 | 243 | $1.34B |
| Q4 2023 | 227 | $1.14B |
| Q3 2023 | 220 | $1.06B |
| Q2 2023 | 212 | $1.27B |
| Q1 2023 | 185 | $968.0M |
| Q4 2022 | 182 | $876.0M |
| Q3 2022 | 189 | $969.5M |
| Q2 2022 | 180 | $879.0M |
| Q1 2022 | 183 | $872.4M |
| Q4 2021 | 182 | $924.8M |
| Q3 2021 | 195 | $989.0M |
| Q2 2021 | 185 | $1.08B |
| Q1 2021 | 179 | $875.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Lemaitre Vascular Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 0 | $0 | 0.00% | −7,648−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −6,952−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −5,933−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −5,580−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −5,180−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −4,926−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −3,640−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −3,064−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −2,483−100.0% | Sold out |
| Globeflex Capital L P | 0 | $0 | 0.00% | −1,260−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −551−100.0% | Sold out |
| Opal Wealth Advisors, LLC | 0 | $0 | 0.00% | −321−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Whipplewood Advisors, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Congress Wealth Management LLC | – | – | – | – | Not filed |
| Avantax Advisory Services, Inc. | – | – | – | – | Not filed |
| Scott Marsh Financial, LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Teton Advisors, Inc. | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |